Fleks er et oppstartsselskap med mål om å gjøre det enklere og mer fleksibelt å ha bil. Vi leverer et bilabonnement, som betyr at du abonnerer på bilen på månedsbasis uten bindingstid. Alt er inkludert utenom drivstoff og bompenger, og du avslutter abonnementet eller bytter bil etter behov. Utover dette tilbyr vi en rekke tilleggstjenester som du kan inkludere i ditt månedsabonnement.

Apple made one of the most iconic ads “Here’s to the crazy ones” to lift their campaign “Think Different” in 1997. This ad was so “new” and controversial that it since has made history, and is now part of most curriculum in most marketing schools around the globe. It was written by Rob Siltanen, Creative Director for TBWA/Chiat/Day and Creative Director at Apple Lee Clow. It wasn’t Steve Jobs, but it was he who made the quote famous (Originally it was the voice of Richard Dreyfuss in the ad). This, for us marketing geeks, is food for thought, awe and inspiration. Not because of the text itself, Steve as a celebrity, but for what impact that ad had on its audience. Knowing now, in retrospect, the ad was basically describing Steve himself, and beautifully put together with famous “rebels” of their field, we cannot help empathizing and relate to the ad, the history and the text. Don’t get us wrong, we are no rebels. We do not contribute to any groundbreaking tech innovation or have a goal of changing the world. What we believe in, is changing the way advertising is perceived, consumed, and targeted. The glory days of “buying a TV ad and you’re set” have long passed. The effect of “Here’s to the crazy ones” can still be archived, and is our goal in everything we do. We are forever inspired by Steve Jobs, and his rebel being, and we named our company after his ad, written by an agency. The agency does not matter, the sender does.

We are developing a new environmentally friendly technology to replace the existing high energy time-consuming procedure in the greenhouses, to help the farmers grow plants faster with better quality and less consumption of energy. Our treatment can be used to control plant size, quality, and speed of growth, and also to preserve plants for a long period.

Demand for peronal-safe biometric-IDs. If connected you can be hacked and if your IDs are stolen you are digitally-dead. Mobiles and web surveillance are recording our face, fingers and iris pictures. IDs for banking, trade and health must be separated from all the data stored at big-data, governments, secret-services, criminals and social medias. As it is not possible to secure our biometric-IDs 100% we just make stealing IDs not worthwhile. How do we do that? With Cybi-key create your safe Cyber-biometric-IDs from our digital twins. Cybi-IDs the trusted id payment missing today.

Iterate is an ecosystem for digital innovation, and we like to describe ourselves as a company that builds companies. We contribute from A-Z when building, starting with creating concepts based on key insights to launching and improving products whilst living in the marketplace. We find the right team and work toward the company culture that enables us to deliver value to our customers quickly. The key to achieving this is reinvesting all our profits in the ideas of our employees, or selected entrepreneurs. Five years into this strategy, we own shares in fifteen ventures; all of which are showing promising results. Our 70 designers, developers, and product managers just moved into new locations in the center of Oslo. 
Close collaboration with our customers is key to our success. They provide domain know-how, and we provide tools, strategies, and experts. Together we uncover the best way that connects your strategy and idea with the market needs. Our goal is to achieve minimum risk and give our customers the best possible starting point for scaling, on their own, or in continued collaboration.

OncoImmunity is a bioinformatics company providing unique machine-learning software to identify tumor-specific mutations that can be targeted by a patient’s own immune system (known as neoantigens). The OncoImmunity solution is important because recent breakthroughs in the field of Immuno-Oncology (I-O) such as the development of checkpoint inhibitors and personalized cancer vaccines, clearly demonstrate that a patient’s immune system can be harnessed to successfully treat cancer. The cost of identifying tumor-specific mutations in a patient’s cancer using next-generation sequencing (NGS) is now trivial and this technology will be key to enabling truly personalized immunotherapies to be developed in a technically and economically feasible manner. However, the remaining challenge that currently limits the field, and which is addressed by the OncoImmunity solution, is predicting which tumor-specific mutations can stimulate a patient’s immune system i.e. are immunogenic. Using NGS data as input, the OncoImmunity software enables accurate patient selection for cancer immunotherapy and can identify optimal targets for personalized cancer vaccines & cell therapies in a clinically actionable time frame. Beginning from this first product offering, OncoImmunity has the vision to become the world’s leading provider of software to guide cancer immunotherapy to improve survival rates for cancer patients. To achieve this OncoImmunity has assembled a growing team of world-class bioinformaticians, data scientists, and software engineers; developing its cutting-edge machine-learning technology that will help fulfill the promise of immunotherapy in the fight against cancer. OncoImmunity’s technology will disrupt the I-O field by offering regulatory-compliant prediction software on a software-as-a-service basis (SaaS). This will allow big pharma, biotechnology, and immunotherapy companies of any size to access OncoImmunity’s cutting-edge prediction software. The company is headquartered in an ideal scientific and entrepreneurial ecosystem to develop its technology at the Oslo Cancer Cluster Incubator; adjacent to the Institute for Cancer Research and the Norwegian Radium Hospital. OncoImmunity is a privately held company, founded in 2014 by experienced bioinformatics scientists (Dr. Trevor Clancy and Professor Eivind Hovig), and an experienced immunologist with a business development background (Dr. Richard Stratford). The company is backed by private financing from the Norwegian Radium Hospital Research Foundation, the Norwegian Cancer Society, STARTUPLAB, and Grotmol Solutions, in addition to a number of private software investors. The company is also supported by grants awarded from the Norwegian Research Council, Innovation Norway, and the EU. The company has already established both national and international collaborations and pilot projects to develop further proof-of-concept data and validate its software.

We design and create software solutions for an increasingly complex world! --- We are a growing team of thinkers, designers and developers who are passionate about technology and driven by the need for positive change in the world. --- Technologies: Python, GO, C, C++, Javascript, Java, Linux, Embedded, Docker, K8S, Cloud, ArangoDB, Neo4j, RabbitMQ, PostgreSQL, MongoDB, MySQL, Redis, S3, Svelte, React, Node, Git, Gitlab CI, ML, kvm, nginx, lighttpd, Cryptography, ...

Pixotope Technologies is an international, award-winning technology and service company headquartered in Norway. Our flagship product Pixotope® is the world’s leading mixed reality solution for media production that allows media producers and content creators to produce exciting mixed reality content for television, online streaming, and film. Our product and services have been used in some of the largest live productions made in the last few years, such as the Superbowl, League of Legends Championship broadcasts, Euro-vision, and The Weather Channels mixed reality experiences. A selection of these productions can be viewed on our website: https://www.pixotope.com/customers We are a global company with headquarters in Oslo and branch offices in Los Angeles, London, Madrid, and Zagreb. Our customers are from every corner of the world.

VesselMan is a cloud-based management system that enables the digitalization of your value chain .​Digitalization by Vesselman enables improved "ways of work” with closer partnership and distributed value chains, lean processes, and self-service operations that reduce risks, costs, and people dependency.  We help ship owners and ship managers to digitalize the execution of complex dry-docking, conversion, and new building projects by providing a cloud-based management system that is easy to use and easy to implement. We also provide intelligent apps for digital collaboration, ISM safety, asset management, and utilization of IoT and big data. We have signed several well know customers and have recently signed a partnership with Kongsberg Digital in order to take part in their Kognifai platform.

Appivate is a Norwegian company that develops mobile applications. Our primary developing tool is Appcelerator Studio, a program that lets us write a single code and translate it to native Android and iOS at runtime. This makes the development time- and cost-efficient. The primary goal is to satisfy the customers in every single project and to deliver a product that reflects the client´s vision. To ensure that we are on the right path we usually advise our customers to start with a prototype made with a sketch and envision. This makes it easy to determine if the customer and we are on the same wavelength.

ninito makes running a restaurant easier. We provide restaurants with the tools they need to attract more customers, automate processes, and increase revenue all in one solution. Since launching in 2019, we have grown rapidly and now work with some of the best restaurants in the industry. There are over 950 POS systems in the Norwegian market, but both we and our customers believe that ninito is the best at what we do. Want to work for a company that is at the top of its game? Now is your chance. At ninito, you work with the best in the industry and become part of something truly incredible 🚀

Lime Go - a fast growing SaaS 'startup' without any financial or personal risk for you. Wait, what - how?🤔 We are an autonomous business unit within the Lime Technologies Group, giving us the awesome perks of being a Nasdaq-listed company as well as the freedom of a startup. Lime Technologies was founded in 1990 and is the market leader in the Nordics when it comes to CRM. We've had different CRM-products in our portfolio over the years and now it's time to let Lime Go, go big. 🚀 What is the story behind Lime Go?🍑 Lime Go is the ONLY CRM tool for sales and marketing departments with integrated company data. It is excellent for prospecting and filled with valuable company data to help users save time and increase revenue. We help users with their daily work through insights and educate them to be more proactive, providing an ROI from day 1. During 2021 we finished a product redesign to up our game in regard to tech stack, UI, modernity and power. We're now ready to step on the gas pedal and conquer Europe! Who are Lime Technologies and what is Lime Go?🍈 Publicly listed Lime Technologies have a turnover of approx. €40M with 400 employees in 7 countries, divided in 10 offices. We have a local presence in Sweden, Norway, Denmark, Finland, Netherlands, Germany and Poland. Lime Go is part of it and we're a team of 12 people running our own startup unit! The upcoming years will be full speed ahead to recruit and build a team to scale the product for our launch in Europe. Currently we have a strong market position in Sweden with recently launched campaigns in Norway & Denmark - but we have higher ambitions. We will become the most intuitive and user-friendly CRM system in all of Europe and be the obvious choice for ambitious companies. 🌍 Don't hesitate to apply for our open positions and join our team - as we embark on this unique journey!🎢

Aviant performs medical deliveries between hospitals by leveraging drone technology. Today, district hospitals can only analyze simple blood tests themself. The rest have to be transported to test centers, often located at the larger hospitals. Current ground-based transportation logistics between hospitals is unorganized, inefficient, and costly. This new way of transportation will increase the frequency and flexibility of test delivery, as drones can be deployed on an as-needed basis, which will drastically improve the diagnosis process in districts. An analysis posten IEEE showed how drone transportation of biological samples could save the Danish authorities 300 MNOK/year. This commercial potential has been confirmed by our contact with health regions. We currently have three paying contracts: one with St. Olavs Hospital in Trondheim and two in Sweden. Besides our three commercial contracts, we have gotten requests from seven potential customers. To keep up with the demand from the market and take care of our current customers, we need to expand the team.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Praesent ut nulla dolor. Nunc quis maximus mi, ut placerat nulla. Sed id tincidunt purus. Vestibulum sodales congue est, non iaculis arcu suscipit nec. Praesent interdum non ipsum quis cursus. Nullam porta mi sed sodales imperdiet. Vivamus iaculis sem vel dui faucibus, ut rhoncus tellus laoreet. Integer metus nibh, cursus molestie rhoncus eu, cursus ac neque. Integer porttitor dictum dolor, mattis eleifend tellus consectetur nec. Curabitur nunc elit, tincidunt non gravida nec, dictum nec ipsum. Vivamus aliquam posuere diam, non elementum lacus condimentum eu. Aenean eget accumsan leo.

Grentech Innovators AS is dedicated to: Give Waste a value. We are developing new waste management solution by using biotechnology for convertion of organic waste like food waste, into protein and organic fertilizer. The traditional waste management solutions like landfill, composting, biogas production or incineration are all leading to green house gas emission and the economic value of the end product is low or negative. The greenhouse gas Methane is a 72 times more potent greenhouse gas than carbondioxide, and organic waste on landfills are responsible for 11 % of Methane emission. The global aquaculture industry is a great source for healthy food and has been in strong annual growth for decades, but in order to continue growing it is crucial to find new sources for feed,in particular protein and omega-3 oils. The supply of traditional feed sources like fish meal and soy are limited, and there are environmental conserns to increase soy production. In Greentech Innovators we are now investing in a pilot plant for fermentation of food waste into Single cell protein and organic fertilizer in Bergen. We have a dedicated team, and the second largest waste management company in Norway,BIR ,as partner. We are now searching for investors to finalize the pilot palnt and scale up the production. If you are looking for investment in a company that strive to reduce greenhouse gas emissions and increase production of food for the growing population Greentech Innovators is a good choice.